Canatan, D.Bilgen, TürkerÇiftçi, V.Yazıcı, G.Delibaş, S.Keser, İ.2022-05-112022-05-1120161300-7777https://doi.org/10.4274/tjh.2015.0299https://hdl.handle.net/20.500.11776/10604[No abstract available]en10.4274/tjh.2015.0299info:eu-repo/semantics/openAccessAbnormal hemoglobinsHemoglobin fontainebleauHemoglobin G-WaimanaloDNAhemoglobin beta chainhemoglobin fontainebleauhemoglobin g Waimanalohemoglobin variantunclassified drugcodonhemoglobin alpha chainhemoglobin Fontainebleauhemoglobin G Waimanalohemoglobin variantadultalpha gene A1alpha gene A2blood analysisblood cell countcase reportDNA sequencefemalegenegene mutationhematologic diseasehigh performance liquid chromatographyhumanLetternormochromic normocytic anemiapolymerase chain reactionthalassemiaTurk (people)alpha-Thalassemiaasymptomatic diseasecodongeneticsmissense mutationpoint mutationTurkeyAdultalpha-Globinsalpha-ThalassemiaAsymptomatic DiseasesChromatography, High Pressure LiquidCodonFemaleHemoglobins, AbnormalHumansMutation, MissensePoint MutationTurkeyFirst observation of hemoglobin G-waimanalo and hemoglobin fontainebleau cases in the Turkish populationTürk toplumunda gözlenen ilk hemoglobin g-waimanalo ve hemoglobin fontainebleau olguları]Letter33171722-s2.0-8495878717827020723Q3